Aptose Biosciences INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
Aptose Biosciences has filed a registration statement for the potential resale of up to 12,030,218 common shares by Keystone Capital Partners, following a recent purchase agreement.
Aptose Biosciences is offering common shares and warrants, including pre-funded options, to raise capital for working capital and general corporate purposes.
Aptose Biosciences has filed a registration statement for a potential offering of common shares to raise capital for working capital and general corporate purposes.
Aptose Biosciences has filed a registration statement to register up to $3,360,871 in additional securities, including common shares, warrants, and underwriters' warrants.
Aptose Biosciences is launching a public offering of common shares and warrants, aiming to raise $9.9 million to support the development of its cancer treatment pipeline.